Sirona Biochem (TSE:SBM) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sirona Biochem is set to enter the anti-aging market in early 2025 with its first cosmeceutical serum, GlycoProteMim™, which promises rejuvenating benefits. The company has completed the serum’s formulation, is finalizing packaging, and is navigating regulatory steps. With partnerships in key global markets and potential profitability by 2025, Sirona Biochem is gearing up for a significant commercial leap.
For further insights into TSE:SBM stock, check out TipRanks’ Stock Analysis page.